{"id":"W1484310480","doi":"10.1186/ar1428","title":"GATA-3 in human T helper cell type 2 development","year":2004,"lang":"en","type":"article","venue":"Arthritis Research","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Canadian Arthritis Network; School of Medicine, University of California, San Diego; Menzies Institute for Medical Research; National Cancer Institute; Arthritis Society; University of North Carolina at Chapel Hill; Genentech; National Institutes of Health; Biogen; Lupus Research Institute; Pfizer; Natural Sciences and Engineering Research Council of Canada; Dutch Arthritis Association; Oesterreichische Nationalbank; Deutsche Forschungsgemeinschaft; Nuffield Foundation; Physiotherapy Foundation of Canada; Canadian Institutes of Health Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Lupus Research Alliance; Wellcome Trust; Newcastle University; National Institute of Allergy and Infectious Diseases; Howard Hughes Medical Institute; Austrian Science Fund; Arthritis Foundation","keywords":"Cytotoxic T cell; Immunology; Biology; T cell; Cellular differentiation; Immune system; Priming (agriculture); CD8; Cell biology; Interleukin 21; Effector; In vitro; Genetics; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001080114,0.0004280948,0.0003718846,0.0005026397,0.000260448,0.0008629888,0.0007321722,0.0007134574,0.01450466],"category_scores_gemma":[0.0004363417,0.0001862346,0.0004323336,0.0002130565,0.0004988931,0.0003875496,0.0009327356,0.001004975,0.002927131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004305821,"about_ca_system_score_gemma":0.0003272612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005298768,"about_ca_topic_score_gemma":0.0003890511,"domain_scores_codex":[0.9994004,0.0001846278,0.00003502749,0.0001466074,0.0001018978,0.0001315162],"domain_scores_gemma":[0.9997191,0.00008957398,0.0000533456,0.00003275563,0.00003452884,0.00007056032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002957216,0.0003754865,0.02835391,0.001855489,0.0001355313,0.002787207,0.0006887767,0.001722911,0.7831026,0.03111995,0.01406665,0.1328342],"study_design_scores_gemma":[0.0009499361,0.003271375,0.09201231,0.001044532,0.0004026982,0.009268988,0.0008989407,0.007821674,0.3387798,0.01935472,0.5260991,0.0000959239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6930206,0.1698631,0.04904618,0.004244284,0.004285273,0.0006747282,0.005943648,0.001806731,0.0711154],"genre_scores_gemma":[0.951425,0.01006235,0.01320467,0.000965869,0.0005007886,0.0002838892,0.002337993,0.0001318047,0.02108759],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01450466,"threshold_uncertainty_score":0.04852295,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03954916879200016,"score_gpt":0.3247103048534086,"score_spread":0.2851611360614084,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}